These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7536955)

  • 1. [Semiology of urination disorders in men].
    Serment G; Rattier C
    Rev Prat; 1995 Feb; 45(3):292-8. PubMed ID: 7536955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urination disorders in middle-aged men. Adenoma and carcinoma of the prostate].
    Nagel R
    Med Monatsschr; 1968 Apr; 22(4):153-9. PubMed ID: 4177968
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute urine retention in patients with myocardial infarct with adenoma of the prostate gland].
    Shapiro AM; Livshits AI
    Klin Med (Mosk); 1971 Aug; 49(8):62-4. PubMed ID: 4108387
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical diagnosis of benign prostatic hyperplasia].
    Homma Y
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():327-32. PubMed ID: 12599594
    [No Abstract]   [Full Text] [Related]  

  • 6. [General practitioners' approach to urination disorders in men over the age of 50. A survey of 250 physicians in Brittany].
    Coeurdacier P; Staerman F; Thoquenne G; Cipolla B; Guillé F; Lobel B
    Prog Urol; 1996 Feb; 6(1):52-9. PubMed ID: 8624528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in International Prostate Symptom Score, prostrate-specific antigen and prostate volume in patients with benign prostatic hyperplasia followed longitudinally.
    Tsukamoto T; Masumori N; Rahman M; Crane MM
    Int J Urol; 2007 Apr; 14(4):321-4; discussion 325. PubMed ID: 17470162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A current review of medical therapy for benign prostatic hyperplasia.
    Brown GA; Sussman DO
    J Am Osteopath Assoc; 2004 Feb; 104(2 Suppl 2):S11-6. PubMed ID: 15038398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual urine in prostatism estimated by ultrasound scanning: a simple rule.
    Abrams PH; Farman P; Lawrence JP; Sherwood T
    Radiography; 1983 Aug; 49(584):194. PubMed ID: 6194540
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study.
    Roehrborn CG; Siami P; Barkin J; Damião R; Major-Walker K; Morrill B; Montorsi F;
    J Urol; 2008 Feb; 179(2):616-21; discussion 621. PubMed ID: 18082216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
    Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G
    J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urine flowmetry in patients with prostatic adenoma treated with Raveron].
    Steinmetz L; Adamkiewicz K
    Pol Przegl Chir; 1974 Oct; 46(10A):1375-82. PubMed ID: 4139698
    [No Abstract]   [Full Text] [Related]  

  • 13. The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms: at 2 years of followup, does it work?
    Kaplan SA; Olsson CA; Te AE
    J Urol; 1996 Jun; 155(6):1971-4. PubMed ID: 8618299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating symptoms and functional status in benign prostate hyperplasia.
    O'Leary MP
    Br J Urol; 1995 Jul; 76 Suppl 1():25-8. PubMed ID: 7544212
    [No Abstract]   [Full Text] [Related]  

  • 15. The relationship among lower urinary tract symptoms, prostate specific antigen and erectile dysfunction in men with benign prostatic hyperplasia: results from the proscar long-term efficacy and safety study.
    Paick SH; Meehan A; Lee M; Penson DF; Wessells H
    J Urol; 2005 Mar; 173(3):903-7. PubMed ID: 15711315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of lower urinary tract symptoms and prostate enlargement in the primary care setting.
    Naslund MJ; Gilsenan AW; Midkiff KD; Bown A; Wolford ET; Wang J
    Int J Clin Pract; 2007 Sep; 61(9):1437-45. PubMed ID: 17686091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urination disorders caused by prostatic hyperplasia. Effect of Bazoton, Harzol and Prosta-capsules].
    Hallwachs O
    MMW Munch Med Wochenschr; 1981 Oct; 123(44):1675-6. PubMed ID: 6171728
    [No Abstract]   [Full Text] [Related]  

  • 18. [Benign hypertrophy of the prostate].
    Descazeaud A; de La Taille A
    Rev Prat; 2006 Dec; 56(20):2283-9. PubMed ID: 17352329
    [No Abstract]   [Full Text] [Related]  

  • 19. [10 minute consultation: urination disorders in the man].
    Hamm M; Harzmann R
    MMW Fortschr Med; 2004 Apr; 146(15):71-2. PubMed ID: 15373031
    [No Abstract]   [Full Text] [Related]  

  • 20. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
    Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L
    J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.